SERUM URIC ACID CONCENTRATION AND SOME CHRONIC DISEASES IN CHRONIC KIDNEY DISEASE PATIENTS
Main Article Content
Abstract
Background: Hyperuricemia is a common condition in chronic kidney disease and is also associated with hypertension, cardiovascular disease, and diabetes. However, the relationship between serum uric acid and chronic diseases such as hypertension, gout, diabetes, and metabolic syndrome in chronic kidney disease patients is still limited. Method: Cross-sectional study, collecting data on serum uric acid and accompanying diseases such as hypertension, gout, diabetes, and metabolic syndrome in chronic kidney disease patients (or with eGFR of 15-89 mL/min/1.73 m2) has been receiving outpatient treatment at Le Van Thinh Hospital and Ba Ria Hospital. Results: The majority of participants had eGFR of 60–89 mL/min/1.73 m2, corresponding to stage 2 CKD. corresponding to stage 2 CKD. The highest rate of hypertension is 70%. The rate of gout, or MetS, is a third of the study population. Serum uric acid levels tend to gradually increase according to the eGFR subgroup (p<0.001). The rate of hyperuricemia accounts for the majority in gout (p<0.001). There was a difference in serum uric acid levels in the hypertensive and gout groups (p<0.05). Conclusion: This study concludes that serum uric acid levels gradually increase with the stages of CKD, and hypertension is a common condition in patients with hyperuricemia.
Article Details
Keywords
uric acid, chronic disease, chronic kidney disease.
References
2. Ku E, Lee BJ, Wei J, et al. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis. 2019;74(1):120-131.
3. Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, et al. Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020;33(7):583-594.
4. Liu N, Xu H, Sun Q, et al. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. Oxid Med Cell Longev. 2021; 2021: 1470380. doi:10.1155/2021/1470380.
5. Norvik JV, Storhaug HM, Ytrehus K, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. BMC Cardiovasc Disord. 2016;16:85. doi:10.1186/s12872-016-0265-8.
6. Goldberg A, Garcia-Arroyo F, Sasai F, et al. Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease. Am J Nephrol. 2021;52(10-11):837-844.
7. Pugliese G, Penno G, Natali A, et al. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function". J Nephrol. 2020; 33(1): 9-35.
8. Huỳnh Thị Ngọc Ánh, Lê Thị Thúy, Hồ Thị Tuyết Thu và cộng sự. Nồng độ acid uric máu trên bệnh nhân bị bệnh thận mạn tại Bệnh viện C thành phố Đà Nẵng. Tạp chí Y học Việt Nam. 2022; 509(2): 242-246.
9. Đỗ Gia Tuyển, Đặng Thị Việt Hà, Nguyễn Thị An Thủy. Tình trạng rối loạn Acid uric máu ở bệnh nhân suy thận mạn chưa điều trị thay thế. Tạp chí nghiên cứu Y học. 2016;101(3):143-150
10. Lê Hạnh Nguyên, Đỗ Gia Tuyển, Đặng Thị Việt Hà và cộng sự. Đánh giá rối loạn nồng độ acid uric máu ở bệnh nhân bệnh thận mạn chưa điều trị thay thế tại Bệnh viện Đa khoa tỉnh Thanh Hóa. Tạp chí Y học Việt Nam. 2023; 523(1): 134-139.